Indian Pharma Sector Outlook 2026: Defensive Earnings and Global Generics Drive Growth
Indian Pharma Sector Outlook 2026: Defensive Earnings and Global Generics Drive Institutional Flows The pharmaceutical sector enters 2026 with steady global demand, expanding specialty pipelines, and defensive earnings visibility, positioning it as a key institutional allocation during uncertain macro cycles. Indian pharma sector outlook 2026 reflects a balance between defensive earnings stability and long-term growth … Read more